Cubist Systematic Strategies, LLC Repligen Corp Transaction History

Cubist Systematic Strategies, LLC

$14.3 Billion
Q2 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Repligen Corp stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 6,196 shares of RGEN stock, worth $904,182. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,196

Previous 6,196 -0.0%

Holding current value

$904,182

Previous $781,000 -0.0%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $640,680 - $976,770	5,339 Added 622.99%	6,196 $781,000
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $146,358 - $178,615	857 New	857 $157,000
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $5.23 Million - $6.81 Million	37,749 Added 269.0%	51,782 $7.33 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $2.12 Million - $2.72 Million	13,754 Added 4929.75%	14,033 $2.36 Million
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $9.32 Million - $12.7 Million	-57,397 Reduced 99.52%	279 $47,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $4.86 Million - $7.76 Million	30,283 Added 110.55%	57,676 $10.8 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $196,670 - $262,851	-1,398 Reduced 4.86%	27,393 $4.45 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $818,522 - $1.31 Million	5,078 Added 21.41%	28,791 $5.42 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $1.14 Million - $1.4 Million	-4,612 Reduced 16.28%	23,713 $6.28 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $3.56 Million - $5.93 Million	18,289 Added 182.23%	28,325 $8.19 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $1.59 Million - $2.11 Million	-9,560 Reduced 48.79%	10,036 $2 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $2.69 Million - $3.38 Million	14,927 Added 319.7%	19,596 $3.81 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $323,406 - $451,148	-2,184 Reduced 31.87%	4,669 $895,000
Q3 2020 Nov 16, 2020	SELL	$122.51 - $158.27 $4.09 Million - $5.28 Million	-33,362 Reduced 82.96%	6,853 $1.01 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $3.79 Million - $5.65 Million	40,208 Added 574400.0%	40,215 $4.97 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $169 - $218	2 Added 40.0%	7 $1,000
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $1.53 Million - $1.93 Million	-20,749 Reduced 99.98%	5 $0
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $54,651 - $68,098	713 Added 3.56%	20,754 $1.59 Million
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $725,467 - $1.15 Million	13,385 Added 201.1%	20,041 $1.72 Million
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $3.1 Million - $3.94 Million	-62,784 Reduced 90.41%	6,656 $393,000
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $3.32 Million - $4.74 Million	68,840 Added 11473.33%	69,440 $3.66 Million
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $28,080 - $35,382	600 New	600 $33,000
Q4 2017 Feb 14, 2018	SELL	$32.53 - $38.92 $757,558 - $906,368	-23,288 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $861,190 - $1.07 Million	23,288	23,288 $892,000

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

53.9M

Call Options Held

420K

Put Options Held

85.3K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.1B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Repligen Corp Transaction History